Contemporary Management Of Acute Lymphoblastic Leukemia at Meripustak

Contemporary Management Of Acute Lymphoblastic Leukemia

Books from same Author: Pullarkat Vinod

Books from same Publisher: Jaypee Brothers Medical Publishers

Related Category: Author List / Publisher List


  • Price: ₹ 4500.00/- [ 28.00% off ]

    Seller Price: ₹ 3240.00

Sold By: Store4Doctors      Click for Bulk Order

Offer 1: Get 28.00 % + Flat ₹ 75 discount on shopping of ₹ 500 [Use Code: MPSTK75]

Offer 2: Get 28.00 % + Flat ₹ 100 discount on shopping of ₹ 1500 [Use Code: IND100]

Offer 3: Get 28.00 % + Flat ₹ 300 discount on shopping of ₹ 5000 [Use Code: MPSTK300]

Free Shipping (for orders above ₹ 499) *T&C apply.

In Stock

Free Shipping Available



Click for International Orders
  • Provide Fastest Delivery

  • 100% Original Guaranteed
  • General Information  
    Author(s)Pullarkat Vinod
    PublisherJaypee Brothers Medical Publishers
    Edition1
    ISBN9789351522416
    Pages350
    BindingHardcover
    LanguageEnglish
    Publish YearJanuary 2014

    Description

    Jaypee Brothers Medical Publishers Contemporary Management Of Acute Lymphoblastic Leukemia by Pullarkat Vinod

    Acute lymphoblastic leukemia (ALL), the commonest childhood leukemia, is now an eminently curable disease in children, thanks to developments in chemotherapy over the last 6 decades. However, adult ALL still remains a therapeutic challenge, particularly in older patients who are not candidates for intensive chemotherapy or hematopoietic stem cell transplantation (HSCT). Much work, therefore, remains to be done in order to improve outcomes of adult patients as well as patients with relapsed disease. This book is an attempt to compile the latest advances in the understanding of the pathogenesis of ALL as well as various aspects of its treatment.


    Key Features:-

    • Acute lymphoblastic leukemia (ALL), the commonest childhood leukemia, is now an eminently curable di
    • Comprehensive and up-to-date coverage of the epidemiology, molecular pathogenesis, and cytogenetics
    • Extensive discussion of clinical trial data in childhood and adult ALL
    • Chapters devoted to in-depth coverage of key aspects of therapy including use of asparaginase, treat
    • Detailed coverage of emerging areas including minimal residual disease monitoring and pharmacogenomi